China NT Pharma Group Co Ltd
Company Profile
Business description
China NT Pharma Group Co Ltd is a technology-based pharmaceutical company. It is engaged in research and development, production, and sale of private-label drugs, as well as the provision of pharmaceutical marketing and promotion services in China. It focused on the research, development, production, and sales of orthopedic, psychiatric, and oncology drugs. The company operates in a single segment of Proprietary product production and sales. The company earns the majority of its revenue from the domestic market. The Group’s revenue from an external customer was derived solely from its operations in the PRC.
Contact
198 Wellington Street
28th Floor, The Wellington
Sheung Wan
Hong Kong
HKGT: +852 31674238
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
22
Stocks News & Analysis
stocks
Strong result for ASX insurer but not the new norm
stocks
Eli Lilly earnings: Weak Orforglipron obesity data weighs down a strong quarter
stocks
Solid 2025 for A-REIT but development activity will weigh on 2026
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,117.60 | 41.00 | 0.45% |
CAC 40 | 7,725.92 | 17.08 | -0.22% |
DAX 40 | 24,129.82 | 33.04 | -0.14% |
Dow JONES (US) | 44,175.61 | 206.97 | 0.47% |
FTSE 100 | 9,126.52 | 30.79 | 0.34% |
HKSE | 24,906.81 | 47.99 | 0.19% |
NASDAQ | 21,450.02 | 207.32 | 0.98% |
Nikkei 225 | 41,820.48 | 761.33 | 1.85% |
NZX 50 Index | 12,911.86 | 67.23 | 0.52% |
S&P 500 | 6,389.45 | 49.45 | 0.78% |
S&P/ASX 200 | 8,844.80 | 37.70 | 0.43% |
SSE Composite Index | 3,647.55 | 12.42 | 0.34% |